IBT Vaccines

Scroll
Name
IBT Vaccines
About
Maryland, USA
Current Development Stage
Late preclinical stage
REPAIR Impact Fund Investment
USD 3.9 million
Company Website
www.integratedbiotherapeutics.com

Vaccine

IBT Vaccines is a biotechnology company focused on the discovery of novel vaccines and therapeutics for emerging infectious diseases. IBV’s pipeline includes promising product candidates for bacterial and viral infections. IBV’s bacterial program is focused on countermeasures vs. staphylococcal infections, primarily by targeting a variety of toxins produced by S. aureus.